digplanet beta 1: Athena
Share digplanet:

Agriculture

Applied sciences

Arts

Belief

Business

Chronology

Culture

Education

Environment

Geography

Health

History

Humanities

Language

Law

Life

Mathematics

Nature

People

Politics

Science

Society

Technology

G. V. Prasad
జి.వి. ప్రసాద్
Residence Hyderabad, India
Nationality Indian
Ethnicity Telugu
Alma mater Purdue University
Illinois Institute of Technology
Alagappa College of Technology
Occupation CEO of Dr. Reddy's Laboratories
Religion Hindu
Relatives Kallam Anji Reddy (father-in-law)
Kallam Satish Reddy (brother-in-law)

G. V. Prasad (Telugu: జి.వి. ప్రసాద్) is an Indian business executive, and CEO of Dr. Reddy's Laboratories.[1][2] Prasad studied Chemical Engineering at the Alagappa College of Technology. After completing five semesters, he went on to the Illinois Institute of Technology in Chicago to complete the three remaining semesters. Prasad followed up the engineering degree with a one-year MBA at Purdue University. He won the 'Outstanding Senior Student' Award from the American Institute of Chemists, Chicago chapter in 1982. He earned his Masters in Industrial Administration from Purdue University a year later.[3]

His first exposure to the world of pharmaceuticals was in 1985 with Benzex Labs, a pharmaceutical enterprise that he co-founded. Benzex was later acquired by Dr. Reddys and Prasad returned to the construction business, only to come back to pharmaceuticals in 1990 – this time as the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories[4] and Prasad took over as the vice-chairman and CEO of the merged entity.[5]

Early life[edit]

Prasad, the second child of Syamala and Harischandra Reddy,[6] did his initial schooling at the Vidyaranya High School in Hyderabad, Andhra Pradesh, India. He later moved to his hometown, Nellore, where he finished his schooling at VR High School.[7]

Personal life[edit]

Prasad is married to Anuradha, the daughter of Kallam Anji Reddy, who is the founder of Dr Reddy's Labs.[8] Anuradha is the managing trustee of Dr Reddy's Foundation as well as the founder-director of Saptaparni, an organisation promoting the traditions and culture of India.[9]

Early career[edit]

After completing his Masters, Prasad returned to India and joined his father's construction business, immersing himself in various projects in Karnataka. In 1985, he co-founded Benzex Labs, an API manufacturing company, which was later acquired by Dr Reddy's. He briefly returned to the construction business before reappearing on the pharma landscape in 1990 as managing director of Cheminor Drugs Ltd. Fueled by a spirit of entrepreneurship, Prasad transformed Cheminor into a world class API and Generics manufacturer, largely through his focus on professionalism, good governance and transparency.

In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories and Prasad took over as the vice-chairman and CEO of the merged entity. Prasad is widely credited as the architect of Dr. Reddy's successful global generics strategy. He envisioned newer business platforms like the Custom Pharmaceutical business and Specialty pharmaceuticals and is dedicated to building the innovation side of the business.

Professional affiliations[edit]

  • AP State Committee, WWF-India
  • Member of the Advisory Board, Acumen Fund
  • Member of the Board, Infotech Enterprises Ltd.
  • Member of the Board, Diana Hotels, India
  • Member of the Board, Ocimum Bio Solutions
  • Member, American Chemical Society
  • Member, American Institute of Chemical Engineers
  • Served as Chairman of the CII National Committee on Environment and the Intellectual Property Committee (2006–2007)

References[edit]

External links[edit]


Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/G._V._Prasad — Please support Wikipedia.
This page uses Creative Commons Licensed content from Wikipedia. A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.

813 news items

Deccan Chronicle

Deccan Chronicle
Mon, 07 Mar 2016 12:03:45 -0800

Hyderabad: Consigning its founder Anji Reddy's legacy to history, Dr Reddy's Laboratories (DRL) appears to have changed its drug research policy even as it discarded the company's decades old branding in 2015. “At DRL, our innovation in the early days ...
 
Times of India
Sat, 30 Apr 2016 19:59:48 -0700

Andhra Bank's Navashakti Branch is to be inaugurated at Pedawaltair on May 2 by the State Housing Board project director, GV Prasad. Bank chief manager JV Suryanarayana said the new branch will have all the modern facilities and will be equipped with ...

Forbes India

Forbes India
Sun, 22 Nov 2015 18:38:36 -0800

hen Dr Reddy's Laboratories—India's second-largest drug maker by sales—crossed the billion-dollar turnover mark in 2006, its founder Dr Kallam Anji Reddy wrote a letter to his colleagues thanking them for their dedication. He shared his ambition for ...

Livemint

Livemint
Thu, 03 Sep 2015 19:03:45 -0700

From betting big on developing cheaper copies of biotech drugs to spearheading a new venture to incubate start-ups, Dr Reddy's Laboratories Ltd's chief executive officer G.V. Prasad is focused on preparing the drug maker for the future. In an interview ...

Economic Times

Economic Times
Wed, 06 Apr 2016 06:52:30 -0700

In response to the letter, the country's second-largest drug maker's CEO G V Prasad had said the company is in the process of shifting some of the products from these plants to other facilities and considering third party assessment for its plants. The ...
 
The New Indian Express
Wed, 06 Apr 2016 16:15:00 -0700

In response to that letter, the drug maker's CEO G V Prasad had said the company was in the process of shifting some products from these plants to other facilities and considering third party assessment for its plants. The US agency had also asked the ...

Business Standard

Business Standard
Fri, 07 Aug 2015 07:06:57 -0700

As it expands its generics business, Dr Reddy's Laboratories is also looking for innovative ideas in allied areas. The company is planning investments in new ventures such as digital health and genomics, says Dr Reddy's co-chairman and chief executive ...

Economic Times

Economic Times
Tue, 23 Sep 2014 14:23:15 -0700

In an exclusive interview to ET, Chief Executive Officer G V Prasad opens up about how "jugaad" attitude caused lapses among few Indian drug makers, leading US Food & Drug Administration to impose curbs on some plants. Edited excerpts from the ...
Loading

Oops, we seem to be having trouble contacting Twitter

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!

Searchlight Group

Digplanet also receives support from Searchlight Group. Visit Searchlight